STE Steris PLC
- 231.330
- +5.340+2.36%
- 231.330
- 0.0000.00%
Steris PLC News
Steris PLC Fiscal 2024 Earnings: Surpasses Revenue Forecasts and Adjusted EPS Expectations
STERIS Plc (NYSE:STE) Q4 2024 Earnings Call Transcript
Piper Sandler Reiterates Neutral on Steris, Raises Price Target to $225
Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Neutral and raises the price target from $220 to $225.
US bullish stocks this week | Electric power stocks are popular! Vistra and Constellation both recorded double-digit gains
Good performance boosts stock prices! AppLovin, International Fragrances and Fragrances, and Emerson Electric increased by 12.81%, 12.03%, and 8.49% respectively during the week.
KeyBanc Adjusts Price Target on STERIS to $255 From $253
STERIS (STE) has an average rating of outperform and price targets ranging from $215 to $265, according to analysts polled by Capital IQ.
Needham Reiterates Hold on Steris
Needham analyst Mike Matson reiterates Steris with a Hold.
Q4 2024 STERIS Plc Earnings Call
J.P. Morgan Securities: Reiterated the Steris (STE.US) rating and adjusted from superior to superior market rating, with a target price of $265.00.
J.P. Morgan Securities: Reiterated the Steris (STE.US) rating and adjusted from superior to superior market rating, with a target price of $265.00.
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
JMP Securities analyst David Turkaly reiterates Steris with a Market Outperform and maintains $265 price target.
Steris Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 18.71% JMP Securities → $265 Reiterates Market Outperform → Market Outperform 04/12/2024 — Need
Earnings Call Summary | Steris PLC(STE.US) Q4 2024 Earnings Conference
The following is a summary of the STERIS Plc (STE) Q4 2024 Earnings Call Transcript:Financial Performance:STERIS Plc reported total Q4 revenue growth of 10%, with adjusted earnings per diluted share a
STERIS Plc (STE) Q4 2024 Earnings Call Transcript
STERIS plc (STE) Q4 2024 Earnings Call Transcript
STERIS (STE) Q4 Earnings Match Estimates, Margins Contract
STERIS plc STE reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.41, up 4.8% from the year-ago quarter's figure.
STERIS Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results. The Company Announced Planned Restructuring of Its Healthcare Surgical Business in Europe.
STERIS Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results. The Company Announced Planned Restructuring of Its Healthcare Surgical Business in Europe.
STERIS on Pace for Largest Percent Increase Since May 2023 -- Data Talk
STERIS plc (STE) is currently at $220.66, up $10.58 or 5.03% --Would be highest close since April 1, 2024, when it closed at $221.03 --On pace for largest percent increase since May 11, 2023, when i
Steris Fiscal Q4 Non-GAAP EPS, Revenue Rise; Fiscal 2025 Outlook Set -- Share Rise After Hours
Steris (STE) reported fiscal Q4 adjusted net income late Wednesday of $2.58 per diluted share, up from $2.30 a year earlier. Analysts polled by Capital IQ expected $2.35. Revenue for the quarter ended
STERIS Expects FY25 As Reported Revenue From Continuing Operations To Increase 6.5%-7.5%; Adjusted EPS From Continuing Operations Of $9.05 - $9.25 (Est $9.33)
Capital expenditures are anticipated to be approximately $360 million and free cash flow is expected to be approximately $700 million.
Steris to Restructure in Healthcare Surgical Business in Europe
By Ben Glickman Steris said Wednesday it would begin a targeted restructuring plan focused on its Healthcare surgical business in Europe. The healthcare and dental products company said that it woul
STERIS Plc Q4 Earnings Summary
Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE
Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE
Analysis
Price Target
No Data
